Form 4: Centessa Pharmaceuticals Chief Business Officer Sells Shares
SEC Form 4
Gregory M. Weinhoff, Chief Business Officer of Centessa Pharmaceuticals plc, sold 11,742 ordinary shares at an average price of $15.3831.
Summary
- Gregory M. Weinhoff, the Chief Business Officer of Centessa Pharmaceuticals plc, reported a transaction involving the sale of ordinary shares.
- On October 25, 2024, Weinhoff sold 11,742 ordinary shares at a weighted average price of $15.3831.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 22, 2024.
- Following the transaction, Weinhoff still beneficially owns 183,266 ordinary shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an insider share sale under a pre-arranged trading plan. The sale itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
This filing is a routine disclosure of insider trading activity. It's important to monitor such filings to understand management's perspective on the company's stock and future prospects. However, a single sale doesn't necessarily indicate a negative outlook.
Stakeholder Impact
- The sale of shares by a company officer could be perceived negatively by some shareholders, although the existence of a pre-arranged trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| May 22, 2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| October 25, 2024 | Date of the transaction (sale of shares) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.